Biogen Spinraza Archives | DelveInsight Business Research

Tag: Biogen Spinraza

Spinal Muscular Atrophy Therapies

How Spinal Muscular Atrophy Therapies transform market?

Aug 30, 2019• Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Oncology based Reports, Pharma Consultant

Meet the World’s most expensive drug: Zolgensma

May 27, 2019• Articles

The U.S. FDA recently approved the much talked about Novartis’s drug Zolgensma for treating a life-threatening condition Spinal Muscular...

Spinal Muscular Atrophy Therapies

Spinal Muscular Atrophy: Current and Emerging Therapies

Apr 29, 2019• Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant

Spinal muscular atrophy (SMA) being a rare genetic neuromuscular disorder results in progressive muscle weakness and atrophy. It affects...

Spinal Muscular Atrophy

Can Spinal Muscular Atrophy be treated by Protease Inhibitors?

Apr 24, 2019• Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, new therapeutic target, Pharma Consultant, Snippets • 2 Comments